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Abstract
Background: Mice deficient in the LDL receptor (Ldlr
2/2 mice) have been widely used as a model to mimic human
atherosclerosis. However, the time-course of atherosclerotic lesion development and distribution of lesions at specific time-
points are yet to be established. The current study sought to determine the progression and distribution of lesions in Ldlr
2/2
mice.
Methodology/Principal Findings: Ldlr-deficient mice fed regular chow or a high-fat (HF) diet for 0.5 to 12 months were
analyzed for atherosclerotic lesions with en face and cross-sectional imaging. Mice displayed significant individual
differences in lesion development when fed a chow diet, whereas those on a HF diet developed lesions in a time-dependent
and site-selective manner. Specifically, mice subjected to the HF diet showed slight atherosclerotic lesions distributed
exclusively in the aortic roots or innominate artery before 3 months. Lesions extended to the thoracic aorta at 6 months and
abdominal aorta at 9 months. Cross-sectional analysis revealed the presence of advanced lesions in the aortic sinus after 3
months in the group on the HF diet and in the innominate artery at 6 to 9 months. The HF diet additionally resulted in
increased total cholesterol, LDL, glucose, and HBA1c levels, along with the complication of obesity.
Conclusions/Significance: Ldlr-deficient mice on the HF diet tend to develop site-selective and size-specific atherosclerotic
lesions over time. The current study should provide information on diet induction or drug intervention times and facilitate
estimation of the appropriate locations of atherosclerotic lesions in Ldlr
2/2 mice.
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Introduction
For decades, numerous efforts have been made to determine the
pathogenesis and optimal treatments for atherosclerosis, which,
together with related complications, presents the leading cause of
death in industrialized countries. Clinical and epidemiological
studies have led to the identification of the genetic, environmental,
and inflammatory risk factors of this disease, including dyslipide-
mia, hypertension, diabetes, obesity, smoking, high-fat diet, and
chronic inflammation [1]. Manipulation of lipids levels and
inflammatory factors, and combination therapies constitute the
main treatment approaches for atherosclerosis at present [2].
Mouse models have been widely employed to analyze the
underlying biological mechanisms and optimal drug interventions
of atherosclerosis, in particular, Apoe
2/2 and Ldlr
2/2mice [3].
Apoe-deficient mice have been extensively investigated with
regard to diet, lipoprotein metabolism, and the atherosclerotic
lesion progression process [4,5], resulting in their wide usage as
models to mimic human atherosclerosis. Previous studies have
demonstrated that Ldlr
2/2 mice show moderate lipid levels and
develop no or only mild atherosclerosis when fed a regular chow
diet, in contrast to dramatically elevated cholesterol levels and
prominent lesions all over the aorta after 8 months on the Paigen
diet [6], supporting their utility as promising models for
investigating the pathogenesis of atherosclerosis [7,8,9,10,11,12].
While extensive data have been obtained on lesion development in
Apoe
2/2 mice, atherosclerotic lesion progression over time and
distribution of lesions at specific time-points in Ldlr
2/2 mice
remain to be defined.
Hemodynamic forces are recognized as crucial factors deter-
mining the susceptibility of vascular sites to atherosclerosis [13].
Mouse models develop atherosclerotic lesions reproducibly at
susceptible sites associated with low shear or disrupted flow,
particularly the curvature and branch points of the aorta [4,5].
Lesions in the vascular bed go through the following phases:
initiation as fatty streaks, progression into intermediate lesions, and
development of advanced lesions vulnerable to rupture [2].
Lesions at different or the same vascular sites but with different
‘‘lesion age’’ may show variable responses to different types of
modulation. Accordingly, selection of the appropriate times and
locations for evaluation of lesions is of critical importance. More
recently, researchers have started to use more than one site or
time-point to evaluate lesions [14,15]. Clearly, the specific
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addressed.
In the current study, we quantified atherosclerotic lesion
progression in Ldlr
2/2 mice fed regular chow or high-fat diets
over a long-term period. Lesion locations at specific time-points
were additionally identified. Based on the current findings, we
have expanded the general conception on lesion progression and
determined lesion size and location at multiple time-points in
Ldlr
2/2 mice.
Materials and Methods
Ethics Statement
This study has been approved and supervised by Institutional
Animal Care and Use Committee (IACUC) of Shanghai Institute
of Materia Medica, Chinese Academy of Sciences (IACUC
Approval Number: SIMM-2010-12-WYP-06). All procedures
performed on animals were conducted in strict accordance with
the Guide for the Care and Use of Laboratory Animals (Institute
of Laboratory Animal Resources, Commission on Life Sciences,
National Research Council). All efforts were made to improve
animal welfare and minimize suffering.
Mice and Diets
Male Ldlr
2/2 mice (C57BL/6 background, Jackson Laboratory,
stock number: 002207) were housed in standard cages (6 mice per
cage containing toys) in a temperature- controlled (2362uC)
Specific Pathogen-Free room with 12 h dark/12 h light cycles.
Eight week-old mice were randomly divided into two groups. One
group was fed a regular chow diet, and the other a HF diet
(SLACCAS Co., Ltd. China) containing 21% fat (18% added
cocoa butter and 3% fat within the basic diet), 0.15% cholesterol,
7% casein, 7% sucrose, and 3% maltodextrin. All mice had free
access to water and food, except during a 14 h fast period prior to
blood sample collection. Mice were sacrificed at 0, 1, 3, 6, 9, 12
months after HF or chow diet feeding by cervical dislocation.
Plasma Lipid, Glucose and Blood HBA1c Determination
Blood samples were obtained from the retro-orbital plexus of
14 h-fasted animals anesthetized with isoflurane. Formed elements
and plasma were separated by centrifugation (3000 g, 15 min).
Plasma total cholesterol, total triglyceride, LDL, HDL and glucose
levels were measured enzymatically with commercial kits obtained
from Wako Pure Chemical Industries Ltd. and Sichuan Maker
Biotechnology Co., Ltd. The blood HBA1c level from formed
elements was determined according to instructions of the HBA1c
Assay Kit (Sichuan Maker Biotechnology Co., Ltd.).
Tissue Preparation for en face Analysis
After cervical dislocation, mice were perfused with PBS for a
few minutes and subsequently fixed via perfusion with fixation
solution (4% paraformaldehyde, 5% sucrose and 20 mmol EDTA)
for about 15 min. The heart, along with the attached full-length
aorta including most branching vessels, was detached carefully and
placed in fresh fixation solution. Artery en face analysis was
performed, as described previously, with slight modifications [6].
The heart and surrounding adventitial fatty tissue were removed
under an anatomic microscope. The aorta was opened longitu-
dinally from the aortic root to iliac bifurcation and pinned on a
black silica gel plate. The aorta was rinsed in 70% ethanol after
12 h of fixation, stained with 1% Sudan IV in 50% acetone/35%
ethanol for about 10 min, and destained in 80% ethanol for
5 min. The stained aorta was stored in fixation solution until
images were obtained. Atherosclerotic lesions in full-length aorta,
aortic arch, innominate artery (from the branching point to the Y-
shaped bifurcation), thoracic aorta, and abdominal aorta were
analyzed and quantified relative to the full-length lumen area,
using the Image Pro-Plus 6.0 software.
Tissue Histology and Immunohistochemical Staining
To prepare sections in the aortic sinus and innominate artery
for histological staining, heart and aortic arch were processed as
described previously [5,16]. For lipid Oil-Red O staining, tissues
were frozen in OCT compound (Tissue-Tek) and sectioned at
8 mm thickness. Sections were stained with Oil-Red O for lipid
and counterstained with hematoxylin. For other histological
staining, paraffin sections (5 mm) through the aortic sinus were
obtained. Modified Movat’s pentachrome stain was performed
according to an earlier report [17]. Immunohistochemical staining
for macrophages and vascular smooth muscle cell Actin (SM a-
Actin) was performed as specified in a previous report [18].
Statistical Analysis
Values are presented as means 6 SD, unless otherwise
indicated. P,0.05 was considered statistically significant with the
Student’s t-test or one-way ANOVA, followed by Dunnett’s
Multiple Comparison Test.
Results
Plasma lipid, glucose and blood HBA1c Levels
As shown in Figure 1A, total cholesterol and LDL levels of
Ldlr
2/2 mice on the HF diet increased dramatically in the first two
weeks, followed by a slower increase to final concentrations of
22.0062.33 mmol/L and 15.6061.98 mmol/L, respectively.
Meanwhile, the HDL level was only moderately elevated with
time. Interestingly, the total triglyceride level was not significantly
changed over the entire period (Table 1), consistent with previous
findings [16,19]. In contrast, plasma lipids levels were maintained
at a steady-state over the 12 months of test time in mice on a
regular chow diet (Figure 1C). As reported previously [20,21], the
HF diet induced obesity with an almost one-fold increase in body
weight, compared with only 20.8% weight gain in mice fed a
regular chow diet (Figures 1B and D) in 12 months.
Since the high-fat diet induced obesity in Ldlr
2/2 mice, we
measured the levels of plasma glucose and blood HBA1c, which
serve as the two key markers of diabetes. As shown in Table 2, the
HF diet induced a significant increase in glucose and HBA1c
levels. Ldlr-deficient mice fed the HF diet for various time-periods
displayed similar levels of glucose and HBA1c, which were
significantly higher than those of regular chow-fed mice.
Comparison of the diet groups revealed HBA1c levels of
3.58%60.23% and 3.82%60.19% (t-test, P,0.001) and plasma
glucose values of 6.9261.38 mmol/L and 11.5661.92 mmol/L
(t-test, P,0.001) for Ldlr
2/2 mice fed regular chow and the HF
diet, respectively.
Atherosclerotic lesion progression in full-length aorta
To investigate the progression of atherosclerotic lesions over
time, Ldlr
2/2 mice fed the high-fat or regular chow diets for
various time-periods from 0 to 12 months were sacrificed, and full-
length aortas dissected and stained with Sudan IV. As shown in
Figure 2, no or extremely slight lesions (,2% of the lumen area)
were observed in 0-month HF-fed mice. After 3 months, mice
showed slight lesions localized specifically in the aortic sinus, aortic
arch or innominate artery. Following relatively slow development
over the first 3 months, atherosclerotic lesions were robustly
increased in the subsequent months, and extended to the thoracic
Atherosclerosis Development in Mice Lacking LDLR
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11.23%60.52% and 19.40%66.26% of the lumen areas,
respectively. At the end of the study, 38.06%65.79% of the
lumen area was occupied by confluent lesions distributed from
aortic sinus to the aortic bifurcation of mice fed the HF diet for 12
months.
Lesions in mice maintained on a regular chow diet were
similarly measured over time. Some mice developed slight lesions
in the aortic arch as early as 3 months after chow feeding while
others did not develop lesions, even after 12 months of being
subjected to the same diet (Figure S1). Thus, Ldlr
2/2 mice fed a
chow diet appear to display significant individual differences in
lesion development.
Site selectivity of atherosclerotic lesions over time
To elucidate the relationship between feeding times and lesion
location, aortic arch, innominate artery, thoracic aorta, and
abdominal aorta were separately evaluated for atherosclerotic
lesions. Comparison of locations revealed that lesion initially
occurred in the aortic sinus, aortic arch or innominate artery at 0 to
3 months of HF diet feeding. Lesions in these areas increased until
they occupied most of the surface at 6 months and maintained a
steady-state for the next few months, as shown in Figures2C and D.
Lesions in the innominate artery significantly resemble advanced
human atherosclerotic lesions [17]. Detailed morphological and
histological changes of lesions in this site are shown in Figure S2.
The majority of innominate arteries of Ldlr
2/2 mice on chow diet
Figure 1. Plasma lipids levels and body weights of Ldlr
2/2 mice fed HF or regular chow diets over time. Plasma total cholesterol, LDL
and HDL levels in HF diet-fed (A), and regular chow diet-fed (C) male Ldlr
2/2 mice. Body weights of HF diet-fed (B) and regular chow diet-fed (D) mice.
Data are presented as mean values 6 SEM (n=10).
doi:10.1371/journal.pone.0035835.g001
Table 1. Mean plasma TG levels (mmol/L) in Ldlr
2/2 mice
with increasing times of HF or regular chow diet feeding.
Time (months) HF diet Regular chow diet
0 1.5560.25 1.5560.25
3 2.0060.55 1.2660.23
6 1.5860.69 1.4861.17
9 1.9560.40 1.4760.26
12 1.8060.80 1.7060.49
doi:10.1371/journal.pone.0035835.t001
Table 2. Mean HBA1C and glucose levels in Ldlr
2/2 mice fed
a normal or HF diet over time (from 3 to 9 months).
Time (months) HBA1C (%) Glucose (mmol/L)
Normal diet 3 3.5260.21 6.3361.92
6 3.5760.27 7.4561.16
9 3.6860.04 6.9960.89
HF diet 3 3.9260.12 12.5662.36
6 3.7660.23 10.6860.61
9 3.7960.11 11.0561.62
doi:10.1371/journal.pone.0035835.t002
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characteristics, whereas those of one-month HF diet-fed mice
exhibited lipid-loaded macrophages and tunica media thickening.
By 9 months, advanced lesions characterized by narrowing vessels,
thinning and loss of the fibrous cap, and elastic fragmentation were
present (Figure S2).
In contrast to lesions in the aortic arch and innominate artery,
those in the thoracic aorta were initially detected in mice after 6
months on the HF diet, and developed further over the next 6
months (Figure 2E). Abdominal aorta lesions subsequent to
thoracic aorta lesion development were rarely detected before 9
months of HF feeding, and increased significantly after this time
(Figure 2F).
Atherosclerotic lesion development in the aortic sinus
Cross-sectional analysis provides more information on lesion
thickness and its cellular composition. Accordingly, aortic sinuses
in Ldlr
2/2 mice on the HF diet at 0 to 12 months were sectioned
and stained with Oil-Red O to detect vascular lipids. Mice on a
regular chow diet showed no or small lipid-loaded cells adjacent
the valve attachment sites. With increasing HF diet times, lesions
progressed to multilayered foam cell deposits, fibrous-cap lesions,
or vulnerable thin-cap lesions encircling the aortic sinus
Figure 2. Atherosclerotic lesion progression and location in HF diet-fed Ldlr
2/2 mice. Analysis of atherosclerotic lesions was performed
using the en face method. Representative images of Sudan IV-stained aorta in Ldlr
2/2 mice fed the HF diet for 0 to 12 months (A). Lesion-occupied
areas in full-length aorta (A), aortic arch (C), innominate artery (D), thoracic aorta (E), and abdominal aorta (F) were quantified and expressed as a
percentage of the lumen area in Ldlr
2/2 mice on the HF diet at 0 month (N), 3 months (m), 6 months (.), 9 months (g), and 12 months (h).
doi:10.1371/journal.pone.0035835.g002
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at the greatest rate within 3 months of HF diet feeding. Despite
similar lesion thickness, the aortic sinus became ectatic by 6 to 12
months, which is the main cause of the slight increase in lesion size
after 3 months on the HF diet. Cross-sectional analysis revealed a
parallel lesion development process in the aortic sinus to that in the
full-length aorta described previously [22].
As shown in Figure 4, histological examination disclosed a
progressive increase in lesion complexity in the aortic sinus. Fatty
streak lesions composed predominantly of lipid-loaded macro-
phages transformed into mature lesions with visible sharp, needle-
like cholesterol clefts as early as one month after the HF diet.
Numerous lines of evidence support a pivotal role of cholesterol
crystals in triggering inflammation [23,24,25], and more impor-
tantly, occurrence of plague rupture by perforating fibrous tissues
[26,27]. Thus, cholesterol clefts and fibrous cap consisting of
VSMCs, extracellular matrix secreted by VSMCs, and small
amounts of macrophages (Figure 4) can serve as markers of lesion
stability. Thick fibrous-cap lesion with a necrotic core was evident
at 3 months. Lesions at this stage were quite stable and less
advanced, compared with those observed 6 months or later,
characterized by thin fibrous cap, poor collagen, and expanded
acellular necrotic core (Figure 4). Notably, lesions in the three
individual sinuses (left posterior, right posterior and anterior aortic
sinus) may display different development stages, even at the same
sample timings (Figure 4, aortic sinus at 1 M and 3 M).
Discussion
In the present study, we have documented the time-course of
hyperlipidemia, hyperglycemia, obesity, and most importantly,
atherosclerotic lesions with anatomic location selectivity and
diverse sizes, induced by a high-fat diet in Ldlr
2/2 mice. Thus,
based on the development phases and specific locations of lesions,
diets or candidate drug intervention times and lesion evaluation
sites should be carefully selected.
As reported previously [6,16,28], Ldlr
2/2 mice maintained on a
chow diet exhibited no atherosclerosis or only mild lesions with
significant individual differences. Fat and cholesterol-enriched
diets are commonly used to induce atherosclerotic lesion
development. The Paigen diet (1.25% cholesterol, 7.5% cocoa
butter, 7.5% casein, and 0.5% sodium cholate) was initially used to
induce atherosclerosis in Ldlr
2/2 mice [6]. However, sodium
cholate may cause hepatic steatosis and exerts pleiotropic effects
that interfere with the interpretation of data collected during
atherogenesis [29]. In a comparison study of dietary cholesterol
and cholate content, reproducible and comparable lesions were
obtained in Ldlr
2/2 mice fed semipurified diets supplemented with
0.5% or 1.25% cholesterol or a latter diet containing 0.5%
cholate, suggesting that cholate is not necessary for lesion
development in Ldlr
2/2 mice [30]. Teupser and co-workers
further determined the role of cholesterol by raising the cholesterol
content from 0.00% to 0.5%. The group demonstrated that 0.15%
cholesterol is sufficient to induce lesions on the surface of the aorta
[16]. Among the established diets [16,30,31,32,33] to induce
atherosclerosis in Ldlr
2/2 mice, the Western-type diet is the most
widely used high-fat regimen for atherosclerosis experiments,
usually containing 21% fat and 0.15% to 0.25% cholesterol
without cholate [32]. To efficiently induce atherosclerosis and
minimize undesirable effects, a high-fat diet containing 21% fat,
0.15% cholesterol and no cholate was employed in the current
study.
Compared with Apoe
2/2 mice, Ldlr
2/2 mice maintained on
either a regular chow or high-fat diet present a moderate model of
hypercholesterolemia [3]. An earlier study showed that plasma
cholesterol levels were elevated from 5.8160.70 mmol/L to
40.8463.10 mmol/L in male Ldlr
2/2 mice by week 2 of the
Paigen diet [6]. In another study, cholesterol attained a new
equilibrium level following 4 weeks on the AIN76A semisynthetic
diet (0.15% cholesterol) [16]. In the current study, plasma lipids
were determined over a longer time-period of high-fat or regular
chow diet feeding. Mice showed the most significant increases in
plasma lipids levels, including total cholesterol and LDL, in the
first month. Contrary to the speculation that plasma lipids reach
equilibrium levels within 2 to 4 weeks of a Western-type diet
[16,32], the plasma total cholesterol level kept increasing at a slow
rate until 10 months to a final concentration of
22.0062.33 mmol/L in the current study. Compared with
previous data, Ldlr
2/2 mice developed less severe hyperlipidemia
at a relatively slow rate. The different diet components, especially
fat and cholesterol, may at least partly account for this
discrepancy. However, quantitative differences attributable to
the background strains and/or lipid detection assays remain a
possibility.
Figure 3. Aortic sinus lesion morphology in Ldlr
2/2 mice. (A)
Representative sections in Ldlr
2/2 mice fed a regular chow diet (0 M) or
HF diet for 1 to 12 months (1 M, 3 M, 6 M, 9 M, and 12 M) stained with
Oil Red-O and hematoxylin, original magnification: 6100 or 6200, as
indicated; (B) Lesion area was quantified using computer software
IPP6.0.
doi:10.1371/journal.pone.0035835.g003
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aortic sinus is the primary location of atherosclerotic lesion
development [34]. Our cross-sectional and en face images
confirmed this finding in Ldlr
2/2 mice. Moreover, initiation
timing of lesions at different locations were rank-ordered as
follows: aortic sinus.innominate artery.thoracic aorta.abdom-
inal aorta. Given that lesions at different sites of the vascular bed
have distinct ‘‘lesion ages’’, they show variable sensitivity to
manipulations either attenuating or enhancing atherosclerosis.
Inconsistent results were obtained by two different studies focusing
on the effects of the pharmaceutical modifier, T-0901317, on
atherosclerotic lesion progression [15,35]. One group used sample
timing of 2 months after experimental intervention, while the
other selected 3 months. Specifically, in contrast to the significant
anti-atherogenic effects on the aortic sinus reported by the first
group, the latter study found that T091317 was effective in the
innominate artery, rather than the aortic sinus. Based on our data,
at the 2 to 3-month time-period, aortic sinus lesions may be too
progressive to be affected, while innominate artery lesions, which
appear to be initiated later, could be more sensitive to the
manipulation. Thus, sampling before lesion progression substan-
tially is necessary to assess the effects of manipulations that
Figure 4. Atherosclerotic lesion development in the aortic sinus of Ldlr
2/2 mice. A and B, Representative examples of H&E, Movat’s
pentachrome, VSMC-specific Actin and macrophage antibody (Mac-2)-stained aortic sinus sections are provided. In Movat’s pentachrome stained
sections, black represents nuclei and elastin fibers, blue represents ground substance and mucin, yellow represents collagen and reticular fibers, red
represents muscle, and intense red represents fibrinoid and fibrin. The asterisk indicates the classical cholesterol cleft, while NC stands for necrotic
core. The arrow signifies representative regions staining positively for VSMC and macrophage. The bar indicates 200 mm in (A) and 50 mm in (B),
respectively.
doi:10.1371/journal.pone.0035835.g004
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aorta, sample timing should be extended to 3 to 6 months when
lesions are in the linear development stage and can be
manipulated easily. In contrast, for cross-sectional analysis, we
recommended 1 to 3 months as the most susceptible period for
lesion initiation study. Furthermore, for lesion regression or
stability evaluation, longer diet induction or drug modulation
times are required for both en-face and cross-sectional analyses. In
the present study, lesion with necrotic core and fibrous cap formed
by VSMCs and macrophages began to show in one of the 3
individual sinuses at 3 months following initiation of the HF diet
(Figure 4), and subsequently transformed into more advanced and
vulnerable lesion. Thus, depending on the aim of the experimental
manipulation, for example, to prevent initiation of the fatty streak,
inhibit lesion progression, or study the regression of advanced
plaques in Ldlr
2/2 mice, it is necessary to induce the appropriate
lesion patterns using different time-periods of high-fat diet feeding
and careful selection of the anatomic location for lesion analysis.
In summary, Ldlr
2/2 mice represent a moderate atherosclerosis
model that develops lesions in a time-dependent manner with site
specificity. In addition, hyperlipidemia, hyperglycemia, and
inflammation are induced with a long-term high-fat diet. Our
current data obtained with the Ldlr
2/2 mouse model may provide
information on diet induction or drug intervention times and
facilitate estimation of the specific locations of atherosclerotic
lesions in mice.
Supporting Information
Figure S1 Atherosclerotic lesions of normal diet-fed
Ldlr
2/2 mice. Analysis of atherosclerotic lesions was performed
using the en face method. Representative images of Sudan IV-
stained aorta in Ldlr
2/2 mice fed the chow diet for 0, 3, 9, and 12
months.
(TIF)
Figure S2 Atherosclerotic lesion development in the
innominate artery of Ldlr
2/2 mice. Cryosections were
stained with Oil-Red O and paraffin sections with H&E, Movat’s
pentachrome, VSMC-specific Actin and macrophage antibody. In
Movat’s pentachrome stained sections, black represents nuclei and
elastin fibers, blue represents ground substance and mucin, yellow
represents collagen and reticular fibers, red represents muscle, and
intense red represents fibrinoid and fibrin. The arrow indicates
representative regions staining positively for VSMC and macro-
phage. The bar indicates 100 mm.
(TIF)
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